Navigation Links
Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
Date:9/24/2010

12/2011P113701

09/2010P113702

09/2010P122570

02/2011P124817

03/2011NDC 55513-478-10

EPOGEN®

1 mL Multidose, Preserved Solution, 20,000 Units/mL

1005268

04/20111005524

04/20111005525

04/20111005526

04/20111005536

06/20111006028

06/20111006029

06/20111007333

11/20111007334

02/20121011196

02/20121012005

03/20121012006

03/20121012536

04/20121012615

04/20121012616

04/20121012617

04/20121013357

06/20121014239

06/20121014361

08/20121015267

10/20121015501

11/20121015795

09/20121016938

11/20121017383

01/2012P113706

10/2010P122558

02/2011List of PROCRIT lots subject to the voluntary recall:NDCProduct DescriptionPROCRIT®
Lot #Expiration
DateCartonVial59676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

P122494A

02/1159676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G025790A

01/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G025790C

01/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G025790E

01/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G025790G

01/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G040281A

10/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G040281C

10/1259676-302-01

59676-302-00

Cartons containing six (6) single-dose vials: 2000 Units/mL

G040281E

10/1259676-302-01

59676-302-00

Cartons containing six
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Patterson Medical, formerly the ... PDCO ), is now an independent company with ... Patterson Medical by Madison Dearborn Partners (MDP).  ... for a transition period before rebranding as the ... medicine products.  With the focused resources and expertise ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015  Perrigo Company ... that it has completed the acquisition of leading OTC ... at €200 million. The transaction is a clear demonstration ... the Company,s leading European distribution network spanning 36 countries.  ... Joseph C. Papa commented, "We are excited to ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... NEW YORK, Oct. 27 Intercept Pharmaceuticals, Inc., today ... double-blind Phase II clinical trial of INT-747 in ... evaluated the effects of adding one of three doses ... in patients who did not respond adequately to UDCA ...
... Pharmaceuticals, Inc. today announced $4.5 million in Series A and ... complete the company,s ongoing Phase I/IIa trial of BP-GMAX-CD1 in ... for Phase IIb trials. The company anticipates reporting initial results ... new funding brings the total raised to date to $8.5 ...
Cached Medicine Technology:Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis 2Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis 3Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane ... Foundation (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” ... through 9:30 PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... to insufficient scrotal support and protection against dribbled urine and sweat. "In order ... Manhasset Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... NY (PRWEB) , ... August 29, 2015 , ... Next ... end of summer (which astronomically, officially ends on September 22nd this year). For IT ... cyber security hangovers linger on which could prove far more costly than a simple ...
(Date:8/29/2015)... Calgary, AB (PRWEB) , ... August 29, 2015 ... ... congestive heart failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are ... conditions such as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2
... Cross and its,affiliates and The Children,s Hospital of ... seven-year agreement. A term of this length is,unusual ... history of this key partnership.,The extended contract will ... Children,s Hospital, serving the,special health care needs of ...
... 4 Perrigo Company,(Nasdaq: PRGO ; TASE) ... mg,Omeprazole delayed released tablets to its retail customers. ... dose as Prilosec OTC(R). Under terms,of an agreement ... exclusive marketer and distributor for the store brand ...
... For patients with acute kidney injury (AKI), an external ... injured kidneys and significantly reduces the risk of death, ... May Journal of the American Society of Nephrology. , ... and effective for desperately ill patients with AKI. ...
... DETROIT, March 4 Metro Parent and Henry Ford ... known TV,and movie personality, and best-selling author of Louder ... metro Detroit area. McCarthy will,be the keynote speaker at ... the Troy Hilton, an event designed to educate locals ...
... similar prevalence of adverse drug reactions in the treatment ... likely than their male counterparts to be treated with ... by researchers at Rush University Medical Center. The study ... Gender Medicine. , Developments in disease recognition and novel ...
... ANNAPOLIS, Md., March 4 Dozens of ... gathered in Annapolis today as,the General Assembly ... regulations, protections against identity theft, and the ... visited legislators,offices and attended committee hearings on ...
Cached Medicine News:Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 2Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 3Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 2Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 3Health News:'Renal Assist Device' reduces risk of death from acute kidney failure 2Health News:TV Personality and Best-Selling Author Jenny McCarthy Comes to Detroit to Share Her Story of the Struggles and Triumphs of Raising Her Son, Evan, During a Day-Long Autism Workshop 2Health News:Women are treated less frequently than men with statins, aspirin and beta-blockers 2Health News:Utilities, Long Term Care Bills at Center of 'AARP Day In Annapolis' 2
... is a mini glaucoma ... of filtration surgery for patients ... trabeculectomy, the shunt reduces the ... humor from the anterior chamber ...
... rings, Type 14, 14A and 14C have been ... diameters to accommodate the variations in the size ... capsular tension rings are designed to stabilize the ... a large panel of U.S. ophthalmologists. For ...
Hardee bone rongeur made with the highest quality to meet the exacting standards expected in your surgical specialty....
Traditional design utility pliers have adjustable jaws. Good all purpose plier for handling Steinmann Pins, K-Wires, screws and rods. 10mm jaw tip....
Medicine Products: